FEBO, FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 290
EU - Europa 210
AS - Asia 167
SA - Sud America 21
AF - Africa 6
Totale 694
Nazione #
US - Stati Uniti d'America 286
SG - Singapore 75
CN - Cina 55
IT - Italia 50
IE - Irlanda 34
SE - Svezia 34
BR - Brasile 20
GB - Regno Unito 19
UA - Ucraina 19
FR - Francia 17
TR - Turchia 15
VN - Vietnam 11
DE - Germania 9
IN - India 6
NL - Olanda 5
CA - Canada 4
ES - Italia 4
FI - Finlandia 4
BE - Belgio 3
RU - Federazione Russa 3
ZA - Sudafrica 3
AT - Austria 2
CZ - Repubblica Ceca 2
EG - Egitto 2
PL - Polonia 2
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
EE - Estonia 1
HK - Hong Kong 1
JP - Giappone 1
KE - Kenya 1
LT - Lituania 1
PT - Portogallo 1
UZ - Uzbekistan 1
Totale 694
Città #
Chandler 56
Singapore 49
Dublin 29
Jacksonville 24
Beijing 20
Dallas 18
Ashburn 15
Dearborn 15
Princeton 14
Pescara 13
Izmir 12
Nanjing 10
Los Angeles 6
New York 6
Southend 6
The Dalles 6
Buffalo 4
Cambridge 4
Ho Chi Minh City 4
Santa Clara 4
São Paulo 4
Wilmington 4
Altamura 3
Ancona 3
Brussels 3
Johannesburg 3
Nanchang 3
Phoenix 3
Raleigh 3
Tongling 3
Viterbo 3
Alexandria 2
Ann Arbor 2
Boardman 2
Brno 2
Brooklyn 2
Denver 2
Dong Ket 2
Helsinki 2
Jinan 2
Little Rock 2
London 2
Milan 2
Munich 2
Poplar 2
Rome 2
Roselle 2
Tianjin 2
Warsaw 2
Andover 1
Aparecida de Goiânia 1
Araxá 1
Asheville 1
Baku 1
Basciano 1
Bauru 1
Belém 1
Biên Hòa 1
Boston 1
Bến Tre 1
Chapel Hill 1
Charlotte 1
Chesapeake 1
Chieti 1
Clermont 1
Como 1
Cotia 1
Council Bluffs 1
Edinburgh 1
Embu das Artes 1
Fairfield 1
Feira de Santana 1
Felixlândia 1
Frankfurt am Main 1
Fuzhou 1
Haikou 1
Hangzhou 1
Hanoi 1
Helena 1
Hong Kong 1
Houston 1
Isernia 1
Jardim Alegre 1
Jizzakh 1
Kocaeli 1
Konya 1
L'aquila 1
Lanzhou 1
Lousã 1
Monmouth Junction 1
Montes Claros 1
Montreal 1
Montréal 1
Mosciano Sant'Angelo 1
Mumbai 1
Nairobi 1
Natal 1
Norwalk 1
Olavarría 1
Paris 1
Totale 437
Nome #
A comparative safety review between GLP-1 receptor agonists and SGLT2 inhibitors for diabetes treatment 166
[Type 2 diabetes treatment and cardiovascular risk: what can we learn from trials?] 120
Serum FT3 levels and FT3/FT4 ratio as predictors for poor prognosis in hospitalized COVID-19 patients 109
Risk of recurrence in differentiated thyroid carcinoma one year after total thyroidectomy and radioiodine treatment 99
Differentiated thyroid carcinoma one year after ablation 89
Exenatide Once Weekly: Effectiveness, Tolerability, and Discontinuation Predictors in a Real-World Setting 87
Le Magrezze 55
Totale 725
Categoria #
all - tutte 3.115
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.115


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202127 0 0 0 0 0 8 4 5 4 1 2 3
2021/202251 0 0 0 10 0 0 1 3 5 1 12 19
2022/2023144 13 20 9 16 15 22 4 17 15 6 2 5
2023/202447 3 2 5 0 0 12 11 0 0 4 1 9
2024/2025126 5 22 18 2 4 8 4 11 12 7 16 17
2025/2026144 26 12 23 37 32 14 0 0 0 0 0 0
Totale 725